Barclays Increases Integral Ad Science (NASDAQ:IAS) Price Target to $13.00

Integral Ad Science (NASDAQ:IAS) had its price objective increased by Barclays from $12.00 to $13.00 in a report issued on Monday morning, Benzinga reports. The brokerage currently has an equal weight rating on the stock.

A number of other equities research analysts have also issued reports on IAS. Benchmark reiterated a hold rating on shares of Integral Ad Science in a report on Monday. Raymond James increased their price target on Integral Ad Science from $13.00 to $15.00 and gave the company an outperform rating in a research report on Friday, August 2nd. Morgan Stanley boosted their price target on shares of Integral Ad Science from $12.00 to $13.00 and gave the stock an equal weight rating in a report on Tuesday, July 23rd. Craig Hallum reduced their price objective on shares of Integral Ad Science from $20.00 to $18.00 and set a buy rating on the stock in a report on Friday, May 10th. Finally, Loop Capital initiated coverage on shares of Integral Ad Science in a research note on Tuesday, April 30th. They set a buy rating and a $15.00 target price for the company. Three analysts have rated the stock with a hold rating and ten have given a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of Moderate Buy and an average price target of $16.58.

Integral Ad Science Price Performance

Shares of IAS opened at $10.62 on Monday. The firm has a 50-day simple moving average of $9.90 and a two-hundred day simple moving average of $10.90. The company has a debt-to-equity ratio of 0.13, a current ratio of 4.32 and a quick ratio of 4.32. Integral Ad Science has a 1-year low of $7.98 and a 1-year high of $17.53. The stock has a market cap of $1.70 billion, a PE ratio of 1,062.00, a P/E/G ratio of 1.47 and a beta of 1.54.

Integral Ad Science (NASDAQ:IAS) last posted its quarterly earnings data on Thursday, August 1st. The company reported $0.05 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.02 by $0.03. Integral Ad Science had a return on equity of 0.32% and a net margin of 0.57%. The firm had revenue of $129.01 million for the quarter, compared to the consensus estimate of $126.31 million. During the same quarter in the previous year, the business earned $0.05 EPS. The company’s quarterly revenue was up 13.5% compared to the same quarter last year. As a group, analysts forecast that Integral Ad Science will post 0.22 EPS for the current year.

Insider Transactions at Integral Ad Science

In related news, CAO Alexis Gil II sold 2,792 shares of the firm’s stock in a transaction dated Tuesday, June 4th. The stock was sold at an average price of $9.09, for a total transaction of $25,379.28. Following the transaction, the chief accounting officer now owns 145,550 shares of the company’s stock, valued at $1,323,049.50. The transaction was disclosed in a filing with the SEC, which is accessible through this link. In other Integral Ad Science news, CFO Tania Secor sold 4,564 shares of the business’s stock in a transaction on Monday, July 8th. The shares were sold at an average price of $9.68, for a total value of $44,179.52. Following the transaction, the chief financial officer now directly owns 243,101 shares of the company’s stock, valued at approximately $2,353,217.68. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CAO Alexis Gil II sold 2,792 shares of the business’s stock in a transaction dated Tuesday, June 4th. The stock was sold at an average price of $9.09, for a total transaction of $25,379.28. Following the transaction, the chief accounting officer now owns 145,550 shares in the company, valued at $1,323,049.50. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 23,785 shares of company stock worth $240,225. Insiders own 2.00% of the company’s stock.

Institutional Investors Weigh In On Integral Ad Science

A number of institutional investors have recently added to or reduced their stakes in the business. Ameritas Investment Partners Inc. boosted its stake in shares of Integral Ad Science by 40.1% in the first quarter. Ameritas Investment Partners Inc. now owns 6,724 shares of the company’s stock valued at $67,000 after buying an additional 1,924 shares in the last quarter. ProShare Advisors LLC purchased a new stake in Integral Ad Science during the first quarter worth about $121,000. American Trust grew its position in Integral Ad Science by 18.0% during the first quarter. American Trust now owns 13,742 shares of the company’s stock worth $137,000 after buying an additional 2,096 shares during the period. Vontobel Holding Ltd. purchased a new position in Integral Ad Science in the fourth quarter valued at about $176,000. Finally, Price T Rowe Associates Inc. MD lifted its position in shares of Integral Ad Science by 55.8% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 19,215 shares of the company’s stock valued at $192,000 after acquiring an additional 6,878 shares during the period. Hedge funds and other institutional investors own 95.78% of the company’s stock.

About Integral Ad Science

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.